Lilly Holding GmbH

Lilly Holding GmbH Firmenkenndaten im Überblick

Product Range

Pharmaceuticals for treatment of cancer, diabetes, osteoporosis, growth hormone disorder, schizophrenia, depression, ADHD, erectile dysfunction

Key Research Areas Lilly Holding GmbH

Diabetes, Oncology, Neurology – including Alzheimer’s, autoimmune disorders, and pain
(All data based on corporate information from member Lilly Holding GmbH , as of: 10/2015)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download